[Tumor marker in lung cancer].
Shijubo
N
N
Department of Internal Medicine (Section 3), Sapporo Medical University School of Medicine.
Abe
S
S
D000230:Adenocarcinoma / Q000175:diagnosis; D000951:Antigens, Neoplasm / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis*; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry; D002272:Carcinoembryonic Antigen / Q000032:analysis; D018288:Carcinoma, Small Cell / Q000175:diagnosis; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis; D005293:Ferritins / Q000032:analysis; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis*; D010455:Peptides / Q000032:analysis; D010751:Phosphopyruvate Hydratase / Q000032:analysis; D010996:Pleural Effusion / Q000737:chemistry; D015843:Serpins; D019396:Tissue Polypeptide Antigen; D000509:alpha-Fetoproteins / Q000032:analysis
D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D010455:Peptides; D015843:Serpins; D019396:Tissue Polypeptide Antigen; D000509:alpha-Fetoproteins; C051072:squamous cell carcinoma-related antigen; D005293:Ferritins; D010751:Phosphopyruvate Hydratase